These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7932524)

  • 1. Synthesis and biological activity of 3-[2-(dimethylamino)ethyl]-5-[(1,1-dioxo-5-methyl-1,2,5-thiadiazolidin- 2-yl)-methyl]-1H-indole and analogues: agonists for the 5-HT1D receptor.
    Castro JL; Baker R; Guiblin AR; Hobbs SC; Jenkins MR; Russell MG; Beer MS; Stanton JA; Scholey K; Hargreaves RJ
    J Med Chem; 1994 Sep; 37(19):3023-32. PubMed ID: 7932524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy.
    Xu YC; Johnson KW; Phebus LA; Cohen M; Nelson DL; Schenck K; Walker CD; Fritz JE; Kaldor SW; LeTourneau ME; Murff RE; Zgombick JM; Calligaro DO; Audia JE; Schaus JM
    J Med Chem; 2001 Nov; 44(24):4031-4. PubMed ID: 11708905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptors.
    Street LJ; Baker R; Castro JL; Chambers MS; Guiblin AR; Hobbs SC; Matassa VG; Reeve AJ; Beer MS; Middlemiss DN
    J Med Chem; 1993 May; 36(11):1529-38. PubMed ID: 8496922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-induced contraction in canine coronary artery and saphenous vein: role of a 5-HT1D-like receptor.
    Cushing DJ; Baez M; Kursar JD; Schenck K; Cohen ML
    Life Sci; 1994; 54(22):1671-80. PubMed ID: 7909909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.
    Valentin JP; Bonnafous R; John GW
    Br J Pharmacol; 1996 Sep; 119(1):35-42. PubMed ID: 8872354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-[(3-nitropyrid-2-yl)amino]indoles: novel serotonin agonists with selectivity for the 5-HT1D receptor. Variation of the C3 substituent on the indole template leads to increased 5-HT1D receptor selectivity.
    Macor JE; Blank DH; Fox CB; Lebel LA; Newman ME; Post RJ; Ryan K; Schmidt AW; Schulz DW; Koe BK
    J Med Chem; 1994 Aug; 37(16):2509-12. PubMed ID: 8057297
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists.
    Slassi A; Edwards L; O'Brien A; Meng CQ; Xin T; Seto C; Lee DK; MacLean N; Hynd D; Chen C; Wang H; Kamboj R; Rakhit S
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1707-9. PubMed ID: 10937729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: potent agonists for 5-HT1D receptors.
    Street LJ; Baker R; Davey WB; Guiblin AR; Jelley RA; Reeve AJ; Routledge H; Sternfeld F; Watt AP; Beer MS
    J Med Chem; 1995 May; 38(10):1799-810. PubMed ID: 7752204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
    Choi SK; Green D; Ho A; Klein U; Marquess D; Taylor R; Turner SD
    J Med Chem; 2008 Jun; 51(12):3609-16. PubMed ID: 18507369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
    Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
    Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided design and synthesis of 5-substituted tryptamines and their pharmacology at the 5-HT1D receptor: discovery of compounds with potential anti-migraine properties.
    Glen RC; Martin GR; Hill AP; Hyde RM; Woollard PM; Salmon JA; Buckingham J; Robertson AD
    J Med Chem; 1995 Sep; 38(18):3566-80. PubMed ID: 7658443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
    J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological activity of novel dimethyl-[2-[6-substituted-indol-1-yl]-ethyl]-amine as potent, selective, and orally-bioavailable 5-HT(1D) agonists.
    Isaac M; Slassi M; Xin T; Arora J; O'Brien A; Edwards L; MacLean N; Wilson J; Demschyshyn L; Labrie P; Naismith A; Maddaford S; Papac D; Harrison S; Wang H; Draper S; Tehim A
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4409-13. PubMed ID: 14643336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.
    Filla SA; Mathes BM; Johnson KW; Phebus LA; Cohen ML; Nelson DL; Zgombick JM; Erickson JA; Schenck KW; Wainscott DB; Branchek TA; Schaus JM
    J Med Chem; 2003 Jul; 46(14):3060-71. PubMed ID: 12825944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-694,247: a potent 5-HT1D receptor agonist.
    Beer MS; Stanton JA; Bevan Y; Heald A; Reeve AJ; Street LJ; Matassa VG; Hargreaves RJ; Middlemiss DN
    Br J Pharmacol; 1993 Nov; 110(3):1196-200. PubMed ID: 8298808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential.
    Saxena PR; De Vries P; Heiligers JP; Bax WA; Maassen VanDenBrink A; Yocca FD
    Eur J Pharmacol; 1998 Jun; 351(3):329-39. PubMed ID: 9721025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.
    Glennon RA; Lee M; Rangisetty JB; Dukat M; Roth BL; Savage JE; McBride A; Rauser L; Hufeisen S; Lee DK
    J Med Chem; 2000 Mar; 43(5):1011-8. PubMed ID: 10715164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
    Mattsson C; Svensson P; Boettcher H; Sonesson C
    Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine.
    Bou J; Domènech T; Puig J; Heredia A; Gras J; Fernández-Forner D; Beleta J; Palacios JM
    Eur J Pharmacol; 2000 Dec; 410(1):33-41. PubMed ID: 11134654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and serotonergic activity of arylpiperazide derivatives of serotonin: potent agonists for 5-HT1D receptors.
    Perez M; Fourrier C; Sigogneau I; Pauwels PJ; Palmier C; John GW; Valentin JP; Halazy S
    J Med Chem; 1995 Sep; 38(18):3602-7. PubMed ID: 7658447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.